Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041184	u-inh-o	— (—)	48	123	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging of lung

10.89

17.43

2.1

2.8

—

Tuberculosis

42.27

17.28

2.8

1.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

8.00

13.66

2.1

2.7

—

ILD medications: immunosuppressive drugs

8.53

12.24

2.4

2.6

—

Certain infectious and parasitic diseases

9.02

10.14

2.8

2.7

—

L04AX Other immunosuppressants

6.36

8.51

2.6

2.8

—

Second line medication for Crohn's disease

6.09

8.17

2.6

2.9

—

Excluding asthma or asthma-COPD overlap

7.51

7.55

2.3

2.9

—

COPD differential diagnosis

7.51

7.55

2.3

2.9

—

ILD differential diagnosis

7.51

7.55

2.3

2.9

—

Persons with potential health hazards related to communicable diseases

6.82

7.07

2.8

2.2

—

GASTRO-related operations

7.81

5.66

2.4

3.0

—

Any gastric operation

7.81

5.66

2.4

3.0

—

ILD medications

4.12

5.61

2.6

2.4

—

Other pulmonary diagnosis

6.01

5.14

2.5

2.9

—

Autoimmune diseases excluding thyroid diseases

3.93

5.06

2.8

2.3

—

Polyarthropathies

4.06

4.64

2.2

2.8

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.77

4.57

2.2

2.4

—

First line medication for Crohn's disease

3.57

4.47

2.3

2.7

—

Diseases of the respiratory system

5.51

4.39

1.9

3.2

—

Asthma, unspecified (mode)

9.06

4.11

3.0

2.7

—

Examination and observation for other reasons

5.07

4.04

3.5

2.0

—

Autoimmune diseases

3.40

3.88

2.6

2.3

—

Neurological diseases

3.71

3.77

2.5

2.7

—

Asthma, unspecified (mode), excluding more controls

9.16

3.66

3.1

2.8

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.37

3.61

2.9

2.7

—

3.37

3.61

2.9

2.7

—

Disorders of other endocrine glands

5.54

3.60

2.0

2.8

—

Used for control exclusion in common control thyroid runs

3.31

3.50

2.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.39

3.50

2.9

2.3

—

Abnormalities of breathing

3.33

3.49

2.9

2.5

—

Pneumonias (Asthma/COPD co-morbidities)

3.13

3.35

2.9

2.5

—

Rheumatoid arthritis

5.60

3.24

2.0

3.2

—

Gout, FINNGEN

6.37

3.18

2.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.22

3.13

3.0

2.0

—

Asthma, excluding more controls

5.33

3.12

2.9

3.0

—

Gastrointestinal diseases

4.18

3.08

2.0

1.7

—

Other bacterial diseases

3.10

3.08

2.1

2.9

—

Contact with and exposure to communicable diseases

4.98

3.03

2.1

2.3

—

Disorders of lens

3.71

2.94

2.1

3.1

—

Asthma

4.83

2.92

2.9

—

Influenza and pneumonia

2.88

2.91

2.9

2.5

—

Rheumatoid arthritis, including avohilmo

4.71

2.91

2.0

2.7

—

Asthma (only as main-diagnosis), excluding more controls

5.29

2.88

3.6

3.0

—

Oral corticosteroids

2.82

2.77

2.4

2.5

—

General symptoms and signs

2.92

2.75

2.7

—

Any reimbursement code in KELA

4.51

2.74

2.9

2.4

—

Asthma (only as main-diagnosis)

4.83

2.72

3.6

2.9

—

Autoimmune diseases related-to ILD

3.02

2.68

3.1

2.4

—

Reimbursement for rheumatic diseases

3.74

2.66

1.9

2.9

—

Gout

4.91

2.65

2.6

3.0

—

Disorders of choroid and retina

3.08

2.63

2.5

—

Pneumonia, organism unspecified

2.89

2.60

2.6

—

Visual disturbances and blindness

3.60

2.57

2.8

2.5

—

Bacterial pneumonia (organism specified)

4.05

2.55

2.9

1.9

—

Parasetamol

3.06

2.55

2.5

2.7

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

7.15

2.55

1.6

2.3

—

Sulfasalazine

5.46

2.54

2.0

2.4

—

All pneumoniae

2.72

2.51

3.1

2.4

—

Benign neoplasms

2.70

2.51

1.9

2.8

—

Asthma (mode)

4.39

2.49

3.1

2.9

—

Diseases of the ear and mastoid process

2.62

2.48

2.4

2.7

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.69

2.48

3.1

2.4

—

Papulosquamous disorders

3.81

2.46

3.3

2.6

—

COPD/asthma/ILD related infections

2.70

2.43

2.9

2.7

—

COPD/asthma related infections

2.70

2.43

2.9

2.7

—

Other cataract

4.52

2.43

2.6

3.5

—

ILD, hospital admissions 1, main diag only

6.25

2.37

2.6

1.5

—

ILD, hospital admissions

6.25

2.37

2.6

1.5

—

Interstitial lung disease

6.25

2.37

2.6

1.5

—

Other interstitial pulmonary diseases

6.25

2.37

2.6

1.5

—

Interstitial lung disease endpoints

6.25

2.37

2.6

1.5

—

Spondylopathies

2.90

2.29

1.8

2.8

—

Disorders of lipoprotein metabolism and other lipidaemias

2.88

2.29

3.3

2.4

—

Gout, idiopatic and unspecified

4.62

2.27

2.8

2.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4.62

2.27

1.7

2.4

—

Other/unspecified seropositive rheumatoid arthritis

4.62

2.27

1.7

2.4

—

Seropositive rheumatoid arthritis, wide

4.62

2.27

1.7

2.4

—

Psoriasis

4.62

2.27

3.7

2.6

—

Visual disturbances

3.48

2.26

2.8

2.3

—

Seropositive rheumatoid arthritis

4.61

2.26

1.7

3.5

—

Asthma-related pneumonia

3.88

2.24

3.1

2.4

—

Asthma, hospital admissions 3, pneumonia

3.88

2.24

3.1

2.4

—

Asthma-related pneumonia or sepsis

3.88

2.24

3.1

2.4

—

Other disorders of ear

2.66

2.23

2.3

2.6

—

Pleural effusion

5.56

2.21

1.8

2.0

—

Asthma (diagnoses ohter than nonallergic)

2.69

2.21

3.0

2.3

—

Complications of surgical and medical care, not elsewhere classified

2.61

2.19

2.3

2.6

—

Anti-inflammatory and antirheumatic products, non-steroids

4.40

2.19

1.9

2.6

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3.84

2.19

1.7

2.9

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.83

2.19

2.3

2.8

—

Malignant neoplasm, wide definition for exclusion

2.83

2.19

2.3

2.8

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2.83

2.18

2.3

2.8

—

Diseases of oesophagus, stomach and duodenum

2.55

2.18

2.9

2.5

—

Fever of other and unknown origin

3.37

2.18

2.4

2.5

—

Pure hypercholesterolaemia

2.92

2.16

3.2

2.5

—

Gastro-oesophageal reflux disease

3.07

2.16

2.9

2.4

—

Bacterial infection, other or unspecified

3.28

2.11

2.5

—

General examination and investigation of persons without complaint and reported diagnosis

3.55

2.09

3.0

2.0

—

Other respiratory diseases principally affecting the interstitium

5.00

2.07

2.6

2.0

—

Concussion

3.56

2.04

2.3

2.8

—

Retinal detachments and breaks

4.00

2.04

2.2

2.6

—

External causes of morbidity and mortality

2.95

2.01

2.2

3.4

—

Asthma-related infections

3.03

1.97

2.9

2.5

—

Asthma, hospital admission 2, infections

3.03

1.97

2.9

2.5

—

Persons encountering health services for examination and investigation

3.34

1.95

3.0

2.0

—

Other (seronegative) rheumatoid arthritis, wide

4.55

1.94

1.8

2.7

—

Inflammatory bowel disease treatment related agents

2.38

1.90

2.6

2.5

—

Depression

2.52

1.89

2.3

2.6

—

Diseases of the skin and subcutaneous tissue

2.41

1.89

2.6

2.2

—

Chronic sinusitis

3.53

1.83

2.5

2.8

—

Gout, unspecified

4.17

1.82

2.6

2.5

—

Senile cataract

2.92

1.78

2.1

3.1

—

Aplastic and other anaemias

3.02

1.77

2.6

2.7

—

Intracranial trauma

3.08

1.75

2.3

2.8

—

Unspecified mental disorder

3.33

1.74

1.7

2.6

—

Symptoms and signs involving the circulatory and respiratory systems

2.41

1.74

1.9

2.5

—

2.29

1.73

2.5

2.6

—

Propionic acid derivatives

3.77

1.73

2.0

2.6

—

Chronic lower respiratory diseases

2.27

1.72

3.1

2.2

—

Mycoses

3.85

1.71

3.2

1.7

—

Diseases of the eye and adnexa

2.64

1.70

2.3

2.5

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.80

1.69

2.8

1.6

—

Injury, poisoning and certain other consequences of external causes

2.86

1.68

2.0

3.3

—

Metabolic disorders

2.36

1.63

3.4

2.5

—

Mood [affective] disorders

2.33

1.62

2.3

2.7

—

Mood disorders

2.33

1.62

2.3

2.7

—

Endocrine, nutritional and metabolic diseases

2.54

1.62

2.6

2.4

—

Other chronic obstructive pulmonary disease

3.12

1.60

3.2

2.2

—

Other anaemias

2.89

1.52

2.8

—

Intracranial injury

2.60

1.51

2.7

2.4

—

COPD

2.91

1.50

3.2

2.1

—

Malignant neoplasm

2.37

1.49

1.6

3.0

—

Use of hypnotics and sedatives

2.17

1.48

2.8

2.7

—

Cough

3.20

1.46

1.8

2.3

—

Asthma, hospital admissions , main diagnosis only

2.37

1.45

3.4

2.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.93

1.45

2.7

—

Neoplasms

2.41

1.44

1.6

2.9

—

Diseases of liver

3.13

1.44

3.4

2.5

—

Glaucoma suspect

3.13

1.44

2.6

2.8

—

Other viral diseases

3.12

1.43

3.0

1.9

—

Sensorineural hearing loss

2.33

1.42

2.0

2.8

—

Any mental disorder

2.15

1.40

1.9

2.9

—

Substance abuse, excluding more controls

2.45

1.39

2.0

2.8

—

Coxibs

3.33

1.38

1.6

2.6

—

Bacterial pneumoniae

2.66

1.37

3.3

2.0

—

Bacterial pneumonia, not elsewhere classified

2.65

1.37

3.3

2.0

—

Substance abuse

2.39

1.36

2.0

2.7

—

Diseases of pulp and periapical tissues

2.94

1.36

1.2

2.2

—

Kela-code for severe mental illness

2.94

1.36

1.8

2.6

—

Other diseases of the digestive system

2.94

1.36

1.4

2.5

—

Acetic acid derivatives and related substances

3.26

1.35

1.8

2.6

—

Anxiety (asthma-related co-morbidities)

2.63

1.34

2.0

2.8

—

Conductive and sensorineural hearing loss

2.15

1.31

2.0

2.7

—

Tramadol

2.14

1.29

2.0

2.9

—

Any event in cancer register

2.20

1.29

1.6

2.9

—

Fracture of rib(s), sternum and thoracic spine

2.78

1.28

1.6

2.6

—

Disorders of eyelid, lacrimal system and orbit

2.08

1.27

2.6

—

Later onset COPD

2.80

1.26

3.6

2.2

—

Exposure to other specified factors

2.27

1.26

2.4

2.5

—

Spinal stenosis

2.47

1.25

2.5

2.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.40

1.24

2.5

2.6

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.11

1.23

2.0

2.6

—

Benign neoplasms

2.26

1.23

1.4

3.0

—

Dorsopathies

2.08

1.21

2.4

2.8

—

Heart failure, not strict

2.21

1.21

3.0

2.7

—

Persons encountering health services in other circumstances

2.63

1.21

2.8

2.2

—

Fall on same level involving ice and snow

2.31

1.18

2.3

2.5

—

Congenital malformations, deformations and chromosomal abnormalities

2.30

1.17

2.2

2.6

—

Other diseases of pleura

2.31

1.17

1.8

2.7

—

Dental caries 1 and operation codes, only avohilmo

2.79

1.17

2.0

3.1

—

Dental caries 3 and operation codes, only avohilmo

2.79

1.17

2.0

3.1

—

Asthma, including avohilmo

1.94

1.16

2.8

2.5

—

Diseases of middle ear and mastoid

2.39

1.13

2.7

2.5

—

Bronchitis

1.95

1.11

2.3

2.6

—

Mental and behavioural disorders due to psychoactive substance use

2.28

1.10

2.0

2.6

—

Other and unspecified anaemias

2.42

1.10

3.0

2.8

—

Low back pain

2.25

1.09

2.9

3.0

—

Mood disorders, excluding more controls

2.11

1.08

2.6

2.9

—

Iron deficiency anaemia

2.36

1.07

3.0

2.6

—

Asthma/COPD (KELA code 203)

2.05

1.06

2.8

2.2

—

Renal tubulo-interstitial diseases

2.03

1.06

1.6

2.9

—

Dorsalgia

2.01

1.04

2.4

2.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.98

1.04

2.1

2.6

—

Headache

2.32

1.04

1.2

2.6

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.25

1.02

2.4

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2.29

1.02

2.0

2.9

—

Hypothyroidism, other/unspecified

1.92

1.01

2.1

2.5

—

Persons encountering health services in circumstances related to reproduction

0.00

1.00

0.0

2.2

—

Complications of medical and surgical care

2.01

1.00

2.7

—

Medical observation and evaluation for suspected diseases and conditions

2.56

1.00

2.7

2.0

—

Nutritional anaemias

2.21

1.00

3.0

2.6

—

Accidents

1.88

0.98

2.7

2.8

—

Other external causes of accidental injury

1.88

0.98

2.7

2.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.83

0.97

2.3

2.6

—

Other disorders of skin and subcutaneous tissue

1.94

0.96

1.9

2.8

—

Presence of other functional implants

2.36

0.96

2.2

3.2

—

Other neurological diseases

1.94

0.95

1.9

2.7

—

Tonsillectomy and adenotomy

2.32

0.95

1.5

2.6

—

COPD, hospital admissions

2.31

0.95

3.2

2.5

—

COPD, early/later onset

2.30

0.95

3.2

2.5

—

All anxiety disorders

2.30

0.95

2.0

2.5

—

Anxiety disorders, excluding more controls

1.93

0.94

2.9

—

Glaucoma

2.19

0.92

2.7

—

STROKE

2.19

0.92

3.2

2.8

—

Transient ischemic attack

2.16

0.91

1.7

2.8

—

Other chronic obstructive pulmonary disease, including avohilmo

2.08

0.89

3.2

2.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.06

0.89

2.5

2.8

—

Bleeding

1.88

0.87

2.1

2.5

—

Carpal tunnel syndrome

2.01

0.87

2.2

2.7

—

Neurotic, stress-related and somatoform disorders

1.83

0.86

2.6

2.5

—

Anxiety disorders

1.83

0.86

2.6

2.5

—

Dental pulpitis 1

1.79

0.85

1.4

2.8

—

Dental pulpitis 4

1.79

0.85

1.4

2.8

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.81

0.85

2.0

2.6

—

Heart failure,strict

1.97

0.84

2.5

2.8

—

Symptoms and signs involving the digestive system and abdomen

1.78

0.84

2.8

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1.93

0.84

2.2

2.5

—

Falls/tendency to fall

1.78

0.84

2.4

2.6

—

Dental pulpitis 2

1.78

0.83

1.6

2.9

—

Selective serotonin reuptake inhibitors

1.82

0.82

3.2

2.7

—

All-cause Heart Failure

1.88

0.80

2.5

2.7

—

Heart failure, strict

1.88

0.80

2.5

2.7

—

Other antidepressants

1.80

0.80

2.8

2.7

—

Other diseases of upper respiratory tract

1.74

0.79

2.5

2.6

—

Injuries to the head

1.76

0.79

1.9

2.7

—

Other soft tissue disorders, not elsewhere classified

1.79

0.78

2.0

2.7

—

Finngen Rheumatological endpoints

1.77

0.78

2.0

3.0

—

Other dorsopathies, not elsewhere classified

1.76

0.78

2.6

2.8

—

Psychiatric diseases

1.79

0.78

2.0

2.9

—

Genitourinary diseases

1.95

0.77

1.6

3.4

—

Other heart diseases

2.20

0.76

3.2

2.4

—

Benzodiazepine use

1.73

0.76

2.3

2.5

—

Spondylosis

2.14

0.75

2.4

2.7

—

Lower back pain or/and sciatica

1.69

0.75

2.9

2.6

—

Sleep disorders (combined)

1.69

0.75

1.8

2.6

—

Acute sinusitis

2.12

0.75

3.8

2.6

—

Coxarthrosis

2.12

0.75

2.0

3.1

—

COPD related to multimorbidity

2.10

0.75

2.0

2.5

—

Other arthrosis

2.10

0.75

2.0

2.9

—

Erysipelas

2.07

0.74

2.8

2.7

—

Hypertensive diseases (excluding secondary)

2.08

0.74

2.2

2.6

—

Complications of procedures, not elsewhere classified

1.83

0.73

2.7

2.6

—

Opioids

1.63

0.73

2.1

2.8

—

Diseases of arteries, arterioles and capillaries

1.80

0.72

2.6

2.7

—

Codes for special purposes

2.00

0.72

3.4

2.6

—

Provisional assignment of new diseases of uncertain etiology

2.00

0.72

3.4

2.6

—

Injuries to the thorax

2.00

0.72

1.6

2.4

—

Depression or dysthymia

1.78

0.72

2.7

3.0

—

Open wound of head

1.97

0.72

2.2

2.3

—

Diseases of the digestive system

1.92

0.70

1.4

2.6

—

Coxarthrosis [arthrosis of hip](FG)

1.90

0.69

2.0

3.3

—

Other acute lower respiratory infections

1.83

0.67

2.0

2.7

—

Hypothyroidism, strict autoimmune

1.84

0.67

2.2

2.4

—

Abnormal findings on examination of blood, without diagnosis

1.80

0.66

2.6

2.4

—

Disorders of synovium and tendon

1.80

0.66

2.8

2.6

—

Renal failure

1.76

0.65

1.4

2.8

—

Symptoms and signs involving the urinary system

1.59

0.64

1.9

2.6

—

Other retinal disorders

1.75

0.64

3.0

2.5

—

Infections of the skin and subcutaneous tissue

1.72

0.63

3.4

2.4

—

Arthropathies

1.63

0.62

2.3

2.7

—

Constipation

1.64

0.62

1.6

2.8

—

Dental caries 3

1.57

0.60

2.6

2.7

—

Extrapyramidal and movement disorders

0.00

0.60

0.0

2.8

—

Exposure to unspecified factor

1.55

0.60

2.0

2.7

—

Diseases of pulp and periapical tissues, including avohilmo

1.62

0.59

1.4

2.8

—

Pain (limb, back, neck, head abdominally)

1.54

0.59

2.3

2.7

—

Diseases of the musculoskeletal system and connective tissue

1.67

0.57

2.2

2.8

—

Diabetes medication

1.56

0.56

2.4

2.6

—

Nerve, nerve root and plexus disorders

1.53

0.55

2.3

2.7

—

Episodal and paroxysmal disorders

1.49

0.54

2.7

2.5

—

Acute upper respiratory infections

1.48

0.54

2.9

2.5

—

Soft tissue disorders

1.46

0.54

2.6

2.7

—

Hypertension, essential

1.56

0.53

2.0

2.3

—

Coronary atherosclerosis

1.55

0.53

3.0

2.7

—

Pain in throat and chest

1.53

0.52

2.5

2.6

—

Chronic diseases of tonsils and adenoids

1.52

0.52

3.5

2.5

—

Dental operations

1.56

0.50

3.0

2.2

—

Type 2 diabetes, wide definition

1.57

0.49

2.9

2.7

—

Dyspnoea

1.53

0.48

3.1

2.4

—

Shoulder lesions

1.48

0.47

1.7

2.8

—

Cystitis

1.48

0.47

1.7

2.8

—

Dental pulpitis 2, only avohilmo

1.43

0.46

1.7

2.8

—

Diseases of oral cavity, salivary glands and jaws

1.52

0.45

2.6

2.3

—

Dental caries 3, only avohilmo

1.52

0.45

2.6

—

Antihypertensive medication - note that there are other indications

1.71

0.45

2.4

—

Dental pulpitis 1, only avohilmo

1.49

0.45

1.4

2.7

—

Dental pulpitis 4, only avohilmo

1.49

0.45

1.4

2.7

—

Hernia

1.40

0.45

1.7

2.9

—

Cardiovascular diseases

1.70

0.45

2.2

2.4

—

Dermatitis

1.61

0.43

1.6

2.4

—

Alcohol use disorder, Swedish definition

1.60

0.43

2.4

2.6

—

Varicose veins

1.57

0.42

2.4

2.6

—

Type 2 diabetes

1.40

0.42

2.6

—

Cardiovascular diseases (excluding rheumatic etc)

1.52

0.41

2.4

—

Diabetes, varying definitions

1.37

0.41

2.6

—

Other diseases of urinary system

1.36

0.41

2.0

2.7

—

Diabetes mellitus

1.36

0.41

2.6

—

Medicines for HER+ breast cancer

0.00

0.41

0.0

2.7

—

Ventral hernia

0.00

0.41

0.0

3.1

—

Lyme disease

0.00

0.41

0.0

2.9

—

Other spirochaetal diseases

0.00

0.41

0.0

2.9

—

Speech therapy

0.00

0.41

0.0

2.4

—

Exclusions for E4_PCOS_CONSORTIUM

1.49

0.41

2.6

2.5

—

Other systemic involvement of connective tissue

0.00

0.40

0.0

2.1

—

Obesity, other/unspecified

0.00

0.40

0.0

2.5

—

Combinations of oral blood glucose lowering drugs

0.00

0.40

0.0

3.1

—

Cardiac arrhythmias

1.44

0.39

3.0

2.9

—

1.43

0.39

2.4

2.6

—

Other and unspecified effects of external causes

0.00

0.39

0.0

2.3

—

Systemic connective tissue disorders

0.00

0.39

0.0

2.2

—

Angina pectoris

1.41

0.38

3.2

2.8

—

1.40

0.38

2.4

2.6

—

Emergency coronary revascularization (for ACS)

1.38

0.38

3.2

2.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.38

0.38

2.4

2.6

—

Rotator cuff syndrome

1.38

0.37

2.0

2.6

—

Hypertensive diseases

1.48

0.37

2.0

2.5

—

Hypertension

1.48

0.37

2.0

2.5

—

Other intervertebral disc disorders

1.47

0.36

2.3

3.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.45

0.36

3.0

2.4

—

Dental operations, only avohilmo

1.38

0.32

3.0

2.2

—

Dental caries, including avohilmo

1.38

0.32

2.9

2.7

—

Dental caries 1

1.38

0.32

2.9

2.7

—

Codeine

1.37

0.32

2.0

2.9

—

Disorders of the thyroid gland

1.35

0.31

2.0

2.6

—

Dental caries 1, only avohilmo

1.33

0.31

2.9

2.6

—

Other (not insulin) diabetes medications

1.32

0.31

2.4

2.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.33

0.31

1.7

2.6

—

Type 2 diabetes, strict (exclude DM1)

1.31

0.31

2.4

2.8

—

Type 2 diabetes, definitions combined

1.31

0.31

2.4

2.8

—

Injuries to the wrist and hand

1.30

0.30

2.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.26

0.30

2.9

2.7

—

Type 2 diabetes, definitions combined, including avohilmo

1.26

0.30

2.4

2.7

—

Abdominal and pelvic pain

1.30

0.29

1.9

2.3

—

Fall on same level

0.70

0.27

1.6

2.6

—

Persons encountering health services in other circumstances, wide

1.26

0.26

3.2

2.4

—

Major coronary heart disease event excluding revascularizations

1.33

0.23

3.6

2.7

—

Arthrosis

1.31

0.23

1.8

2.9

—

Dental caries 2, only avohilmo

1.31

0.23

1.6

2.6

—

Dental caries 2

1.27

0.22

1.6

2.6

—

Implicit Sepsis

1.25

0.22

1.2

2.8

—

Major coronary heart disease event

1.24

0.22

3.2

2.7

—

Other menopausal disorders

0.00

0.22

0.0

3.5

—

Statin medication

1.22

0.22

3.4

2.0

—

Disorders of conjunctiva

1.23

0.22

2.8

2.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.22

0.22

2.2

2.6

—

Dysplasia of cervi uteri

0.00

0.21

0.0

3.6

—

Dizziness and giddiness

1.19

0.21

1.8

2.7

—

Disorders of psychological development

0.00

0.21

0.0

1.5

—

Polyp of the female genital tract

0.00

0.21

0.0

3.5

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.6

—

Other disorders of bladder

0.00

0.21

0.0

1.8

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

2.1

—

Parkinson's disease

0.00

0.21

0.0

1.9

—

Other bursopathies

0.00

0.21

0.0

2.5

—

Parkinson's disease, including avohilmo

0.00

0.21

0.0

1.9

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.21

0.0

1.9

—

Lateral epicondylitis

0.00

0.21

0.0

2.5

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.1

—

Valvular operations

0.00

0.21

0.0

2.5

—

Injury of muscle and tendon at lower leg level

0.00

0.21

0.0

2.3

—

Superficial injury of thorax

0.00

0.21

0.0

2.4

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

1.6

—

Benign neoplasm: Rectum

0.00

0.21

0.0

1.9

—

Schizophrenia

0.00

0.21

0.0

2.3

—

Generalized anxiety disorder

0.00

0.21

0.0

1.6

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

1.9

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

2.2

—

Other CVD

0.00

0.21

0.0

2.1

—

Other bacterial intestinal infections

0.00

0.21

0.0

1.9

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

1.5

—

Spondylolisthesis/Spondylolysis

0.00

0.21

0.0

2.9

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

2.5

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

2.2

—

Cervicalgia

0.00

0.21

0.0

2.7

—

Fracture of skull and facial bones

0.00

0.21

0.0

2.3

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

2.7

—

Complications predominantly related to the puerperium

0.00

0.21

0.0

2.9

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

2.4

—

Other systemic involvement of connective tissue (FG)

0.00

0.21

0.0

2.7

—

Allergic contact dermatitis

0.00

0.21

0.0

1.9

—

Migraine with aura and triptan purchases

0.00

0.21

0.0

2.2

—

Aneurysms, operations, SAH

0.00

0.21

0.0

2.0

—

Other diseases of liver

0.00

0.21

0.0

1.9

—

Other and unspecified polyneuropathies, also in other diseases

0.00

0.21

0.0

2.1

—

Benign neoplasm: Sigmoid colon

0.00

0.21

0.0

2.1

—

Coagulation defects, purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.6

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

2.1

—

Adverse effects, not elsewhere classified

0.00

0.21

0.0

1.9

—

Other and unspecified urticaria

0.00

0.21

0.0

1.6

—

Acute pancreatitis

0.00

0.21

0.0

2.4

—

Persistent mood disorders

0.00

0.21

0.0

2.4

—

L02BG Aromatase inhibitors

0.00

0.21

0.0

2.6

—

Nontraumatic intracranial haemmorrhage

0.00

0.21

0.0

1.8

—

Malignant neoplasm of breast, HER-positive

0.00

0.21

0.0

2.8

—

Bipolar affective disorders

0.00

0.21

0.0

2.4

—

Acute pancreatitis (for exclusion)

0.00

0.21

0.0

2.4

—

Other diseases of blood and blood-forming organs, wide

0.00

0.21

0.0

1.9

—

Migraine with aura

0.00

0.21

0.0

2.2

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.20

0.0

2.1

—

Other fall from one level to another

0.00

0.20

0.0

2.1

—

Other noninfective gastroenteritis and colitis

0.00

0.20

0.0

2.4

—

Sleep apnoea

1.20

0.20

2.2

2.6

—

Other heart diseases, wide

1.16

0.19

2.8

2.5

—

Dental caries 3 and operation codes

1.20

0.18

2.9

2.5

—

Dental caries 1 and operation codes

1.20

0.18

2.9

2.5

—

Diabetes, insulin treatment (Kela reimbursement)

1.16

0.18

2.9

2.6

—

Codeine or tramadol medication

1.20

0.17

2.0

2.6

—

Ischemic heart diseases

1.16

0.10

3.0

2.7

—

Ischaemic heart disease, wide definition

1.16

0.10

3.0

2.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.10

0.10

1.2

2.9

—

Biguanides

1.12

0.09

2.7

2.6

—

Sleep apnoea, including avohilmo

1.11

0.09

2.2

2.5

—

Persons encountering health services for specific procedures and health care

1.11

0.08

2.3

2.6

—

Dermatitis and eczema

1.12

0.08

3.0

2.5

—

Metatarsalgia

0.00

0.0

1.8

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.0

1.8

—

Other infectious diseases

0.00

0.0

1.9

—

Specific development disorders of speech and language

0.00

0.0

1.6

—

Allergic purpura

0.00

0.0

1.8

—

Other necrotizing vasculopathies

0.00

0.0

1.8

—

Use of antiglaucoma preparations and miotics

0.00

0.0

1.7

—

Open wound of forearm

0.00

0.0

1.8

—

Benign neoplasm: Transverse colon

0.00

0.0

1.4

—

Autoimmune hyperthyroidism

0.00

0.0

1.7

—

Septal defects

0.00

0.0

1.2

—

Other specified disorders of external ear

0.00

0.0

1.8

—

Other surgical follow-up care

0.00

0.0

1.8

—

Neuromuscular dysfunction of bladder

0.00

0.0

1.6

—

Diseases of peritoneum

0.00

0.0

1.8

—

Amblyopia ex anopsia

0.00

0.0

1.2

—

Overexertion and strenuous or repetitive movements

0.00

0.0

1.7

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.6

—

Malignant neoplasm of testis

0.00

0.0

1.8

—

Injury of muscle and tendon at wrist and hand level

0.00

0.0

2.3

—

Immunodeficiencies

0.00

0.0

1.8

—

Convergent concomitant strabismus

0.00

0.0

1.5

—

Other and/or unspecified nontoxic goitre

0.00

0.0

2.0

—

Early lumbar disc prolapse, operated

0.00

0.0

2.4

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.8

—

Superficial injury of hip and thigh

0.00

0.0

1.7

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.0

1.7

—

Benign neoplasm: Small intestine

0.00

0.0

1.6

—

Antenatal screening

0.00

0.0

1.4

—

Benign neoplasm: Pancreas

0.00

0.0

1.6

—

Otosclerosis

0.00

0.0

1.2

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

1.6

—

Benign mammary dysplasia

0.00

0.0

3.4

—

Suggestive for eosinophilic asthma

0.00

0.0

2.0

—

Malignant neoplasm of oral cavity

0.00

0.0

1.5

—

Malignant neoplasm of brain

0.00

0.0

1.7

—

Malignant neoplasm of bladder

0.00

0.0

1.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.0

1.8

—

Malignant melanoma of skin

0.00

0.0

1.8

—

Cholangitis (primary sclerosing, PSC)

0.00

0.0

1.9

—

Disturbance of activity and attention

0.00

0.0

1.5

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.5

—

Dermatographic urticaria

0.00

0.0

1.6

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.8

—

Superficial injuries involving multiple body regions

0.00

0.0

1.2

—

Other hammer toe(s) (acquired)

0.00

0.0

3.4

—

Giant cell arteritis

0.00

0.0

1.6

—

DVT of lower extremities

0.00

0.0

1.6

—

Retained placenta and membranes, without haemorrhage

0.00

0.0

1.8

—

Unspecified chronic bronchitis

0.00

0.0

2.0

—

Other and unspecified drugs and medicaments

0.00

0.0

1.8

—

Impotence

0.00

0.0

1.8

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.8

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.0

1.4

—

Benign neoplasm of meninges

0.00

0.0

2.0

—

Ménière disease

0.00

0.0

1.9

—

Lactose intolerance

0.00

0.0

1.7

—

Alcohol abuse, main dg

0.00

0.0

2.4

—

Abnormal spermatozoa

0.00

0.0

2.0

—

Artificial opening status

0.00

0.0

1.9

—

Other and unspecified follicular disorders

0.00

0.0

1.8

—

Abnormalities of gait and mobility

0.00

0.0

1.4

—

Polymyalgia rheumatica

0.00

0.0

1.8

—

Contact with heat and hot substances

0.00

0.0

1.7

—

Abnormal involuntary movements

0.00

0.0

1.4

—

Subarachnoid haemorrhage

0.00

0.0

1.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

0.98

0.00

1.8

2.3

—

Faecal incontinence

0.00

0.0

1.2

—

Spirochaetal infections, other/unspecified

0.00

0.0

1.1

—

Prepatellar bursitis

0.00

0.0

1.3

—

Parkinson's disease, strict definition

0.00

0.0

1.7

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

0.0

1.8

—

Schizoaffective disorder

0.00

0.0

1.0

—

L01XE Protein kinase inhibitors

0.00

0.0

1.2

—

Atrophic disorders of skin

0.00

0.0

1.7

—

Mixed hyperlipidaemia

0.00

0.0

1.7

—

Presbycusis

0.00

0.0

1.9

—

Acute posthaemorrhagic anaemia

0.00

0.0

1.6

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.0

1.6

—

Sixth [abducent] nerve palsy

0.00

0.0

1.2

—

Neuralgia and neuritis, unspecified

0.00

0.0

1.2

—

Nontoxic single thyroid nodule

0.00

0.0

2.3

—

Other and unspecified coagulation defects

0.00

0.0

1.7

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.0

1.7

—

Infections of genitourinary tract in pregnancy

0.00

0.0

2.0

—

Pruritus

0.00

0.0

1.7

—

Hodgkin lymphoma, hilmo

0.00

0.0

1.6

—

Acne vulgaris

0.00

0.0

1.4

—

Type 1 diabetes, strict definition

0.00

0.0

1.4

—

Hyperkinetic disorders

0.00

0.0

1.5

—

Burn and corrosion of wrist and hand

0.00

0.0

1.7

—

Oral lichen ruber planus, including avohilmo

0.00

0.0

1.8

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.0

1.6

—

Benign leiomyoma with endometriosis

0.00

0.0

3.5

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.89

0.00

2.2

2.6

—

Parodontitis, under 40 years and operation codes

0.00

0.0

1.9

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.7

—

Oral leukoplakia and related diseases

0.00

0.0

1.5

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.5

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.6

—

Parodontitis, operation under 40 years and operation codes

0.00

0.0

1.9

—

Hepatic failure, not elsewhere classified

0.00

0.0

1.2

—

Pyothorax

0.00

0.0

1.7

—

Eating disorder

0.00

0.0

2.2

—

Other disorders of white blood cells

0.00

0.0

1.2

—

Speech and linguistic disorders

0.00

0.0

1.6

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.0

1.8

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

1.6

—

Injuries to the knee and lower leg

1.00

0.00

2.3

2.6

—

Benign neoplasm: Skin of trunk

0.00

0.0

1.7

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.7

—

Other keratitis

0.00

0.0

2.6

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

0.0

1.6

—

Other obstructive and reflux uropathy

0.00

0.0

1.9

—

Disorder of external ear, unspecified

0.00

0.0

1.2

—

Abscess of anal and rectal regions

0.00

0.0

1.6

—

Viral pneumonia

0.00

0.0

1.5

—

HSIL lesion of the cervix uteri

0.00

0.0

2.3

—

Paralytic ileus

0.00

0.0

1.2

—

Parodontitis, under 40 years, or operation codes

0.00

0.0

1.9

—

Other sexually transmitted chlamydial diseases

0.00

0.0

1.5

—

Other specified/unspecified systemic involvement of connective tissue

0.00

0.0

1.6

—

Muscle strain

0.00

0.0

1.2

—

Scabies

0.00

0.0

1.6

—

Other pulmonary heart/vessel disease

0.00

0.0

1.2

—

Unspecified kidney failure

0.00

0.0

1.8

—

Salpingitis and oophoritis

0.00

0.0

3.1

—

Chondrocostal junction syndrome [Tietze]

0.00

0.0

1.6

—

Other otitis externa (chronic)

0.00

0.0

1.2

—

Lactose intolerance, other/unspecified

0.00

0.0

1.8

—

Episcleritis

0.00

0.0

1.9

—

Acute peritonitis

0.00

0.0

1.9

—

Campylobacter enteritis

0.00

0.0

1.2

—

Rheumatic fever incl heart disease

0.00

0.0

1.6

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

1.9

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

0.0

1.8

—

Alcohol-induced acute pancreatitis

0.00

0.0

1.8

—

Pneumococcal septicemia

0.00

0.0

1.7

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.6

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.0

2.9

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.0

1.4

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

1.7

—

Endometriosis of pelvic peritoneum

0.00

0.0

3.9

—

Benign neoplasm: Rectosigmoid junction

0.00

0.0

1.5

—

Alcohol abuse, main dg, excluding more controls

0.00

0.0

2.0

—

Benign neoplasm of major salivary glands

0.00

0.0

1.7

—

Anankastic personality disorder

0.00

0.0

1.6

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.6

—

Amyloidosis, other/unspecified

0.00

0.0

1.2

—

Extreme obesity with alveolar hypoventilation

0.00

0.0

1.8

—

UC patients in KELA-register (code 208), prior to 1994

0.00

0.0

1.2

—

Dissection of aorta

0.00

0.0

1.8

—

Fibromyalgia

0.00

0.0

1.3

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.3

—

Atrial septal defect

0.00

0.0

1.2

—

Crohn disease (strict definition, all UC cases excluded)

0.00

0.0

1.7

—

Paraplegia, diplegia of upper limbs

0.00

0.0

1.8

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

1.4

—

Benign neoplasm of ovary

0.00

0.0

3.1

—

Calculus of lower urinary tract

0.00

0.0

1.7

—

Benign neoplasm: Descending colon

0.00

0.0

1.6

—

Intermittent heterotropia

0.00

0.0

1.5

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.7

—

Hereditary corneal dystrophies

0.00

0.0

1.2

—

Plantar fascial fibromatosis

0.00

0.0

1.9

—

Achilles tendinitis

0.00

0.0

2.8

—

Rheumatic valve diseases

0.00

0.0

1.6

—

Endometriosis ASRM stages 1,2

0.00

0.0

1.7

—

Bullous disorders

0.00

0.0

1.5

—

Postprocedural disorders of nervous system

0.00

0.0

1.5

—

Other diseases of blood and blood-forming organs

0.00

0.0

1.9

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.0

1.6

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.0

1.9

—

Right bundle-branch block

0.00

0.0

1.4

—

Pericarditis

0.00

0.0

1.4

—

Macular pucker

0.00

0.0

2.3

—

Other contact dermatitis

0.00

0.0

1.8

—

Hypotension

0.00

0.0

1.4

—

Status epilepticus

0.00

0.0

1.5

—

Cholera

0.00

0.0

1.6

—

Benign neoplasm: Parotid gland

0.00

0.0

1.7

—

Arterial embolism and thrombosis

0.00

0.0

1.6

—

Presbyopia

0.00

0.0

1.7

—

Intestinal adhesions without obstruction

0.00

0.0

1.7

—

Benign neoplasm: Cranial nerves

0.00

0.0

1.2

—

Vertical strabismus

0.00

0.0

1.2

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

1.7

—

Benign neoplasm: Cerebral meninges

0.00

0.0

2.0

—

Endocarditis

0.00

0.0

1.8

—

Endometriosis of ovary

0.00

0.0

3.9

—

Atopic conjunctivitis

0.00

0.0

1.6

—

Ectopic pregnancy

0.00

0.0

2.4

—

Other specified/unspecified hearing loss

0.00

0.0

1.7

—

Divergent concomitant strabismus

0.00

0.0

1.8

—

Urethral stricture

0.00

0.0

1.6

—

Aortic valve malfunction, age under 60 years

0.00

0.0

2.9

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.0

1.3

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.0

1.2

—

Other specified disorders of kidney and ureter

0.00

0.0

1.2

—

Trigeminal neuralgia

0.00

0.0

1.8

—

Unspecified/other endometriosis

0.00

0.0

3.0

—

Fracture of neck

0.00

0.0

1.7

—

Cerebral cysts

0.00

0.0

1.6

—

Lesion of lateral popliteal nerve

0.00

0.0

1.8

—

Other neurotic disorders

0.00

0.0

1.5

—

Benign neoplasm: Choroid

0.00

0.0

1.9

—

Other CVD (FINNGEN)

0.00

0.0

2.2

—

Eating disorders

0.00

0.0

1.8

—

Lymphoid leukaemia

0.00

0.0

1.8

—

Other diseases of spinal cord

0.00

0.0

1.7

—

Other demyelinating diseases of the central nervous system

0.00

0.0

1.6

—

Anorexia (incl.atypical)

0.00

0.0

1.5

—

Drug-induced neutropenia

0.00

0.0

1.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.0

1.9

—

Acne

0.00

0.0

1.5

—

Other disorders of the genitourinary system

0.00

0.0

1.9

—

Lesion of ulnar nerve

0.00

0.0

3.0

—

Bicuspidal aortic valve syndrome

0.00

0.0

1.8

—

Other follicular disorders

0.00

0.0

1.7

—

Undefined dementia

0.00

0.0

1.5

—

Infectious mononucleosis

0.00

0.0

1.5

—

Restless leg syndrome

0.00

0.0

1.7

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.4

—

Volume depletion

0.00

0.0

1.6

—

Disorders of mineral metabolism

0.00

0.0

1.6

—

Thrombocytopenia, unspecified

0.00

0.0

1.5

—

Purpura and other haemorrhagic conditions

0.00

0.0

1.7

—

Type1 diabetes, definitions combined, early onset

0.00

0.0

1.4

—

Other and unspecified disorders of white blood cells

0.00

0.0

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

2.0

—

Status post-ami

0.00

0.0

1.6

—

Noninfectious colitis NAS

0.00

0.0

1.7

—

Artrosis, including avohilmo

0.88

0.00

1.8

2.9

—

Lymphoid leukaemia

0.00

0.0

1.9

—

Other disorders of cornea

0.00

0.0

1.8

—

Type 1 diabetes, definitions combined

0.00

0.0

1.5

—

Benign neoplasm: Caecum

0.00

0.0

1.4

—

Carcinoma in situ of skin

0.00

0.0

1.5

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.0

1.7

—

Myeloid leukaemia

0.00

0.0

1.2

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.0

1.2

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.6

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.4

—

Other peripheral vertigo

0.00

0.0

1.6

—

Other and unspecified diseases of blood and blood-forming organs

0.00

0.0

1.7

—

Collagenous colitis

0.00

0.0

1.7

—

Squamous cell neoplasms and carcinomas of the skin

0.00

0.0

1.4

—

Diseases of the myoneural junction and muscle

0.00

0.0

1.8

—

Intracerebral haemorrhage

0.00

0.0

1.4

—

Benign neoplasm: Larynx

0.00

0.0

1.8

—

Malignant neoplasm of small intestine

0.00

0.0

1.2

—

Drug-induced cataract

0.00

0.0

1.2

—

Other and unspecified abdominal hernia

0.00

0.0

1.5

—

Brain meningioma

0.00

0.0

2.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.0

1.5

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.8

—

Urethritis and urethral syndrome

0.00

0.0

1.2

—

Other facial nerve disorders

0.00

0.0

1.8

—

Malignant melanoma

0.00

0.0

1.7

—

Other appendicitis

0.00

0.0

1.7

—

Pneumothorax

0.00

0.0

1.8

—

Unspecified dementia

0.00

0.0

2.0

—

Myopia

0.00

0.0

1.5

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.8

—

Other diseases of biliary tract

0.00

0.0

1.4

—

Malignant neoplasm of eye, brain and central nervous system

0.00

0.0

1.7

—

Graves disease, strict definition

0.00

0.0

1.9

—

Deep bite

0.00

0.0

1.7

—

Malignant neoplasm of pancreas

0.00

0.0

1.5

—

Viral infections of the central nervous system

0.00

0.0

1.8

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.0

1.5

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.0

1.2

—

Nonalcoholic fatty liver disease

0.00

0.0

1.7

—

Disorders of iron metabolism

0.00

0.0

1.2

—

Malignant neoplasm of other connective and soft tissue

0.00

0.0

1.2

—

Varicella [chickenpox]

0.00

0.0

3.0

—

Disorders of muscles

0.00

0.0

1.2

—

Coeliac disease

0.00

0.0

1.8

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.0

1.5

—

Adenocarcinoma of pancreas

0.00

0.0

1.2

—

Non-Hodgkin lymphoma, all

0.00

0.0

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

0.0

1.7

—

Rare circulating lymphoid malignancy

0.00

0.0

1.2

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.8

—

Prurigo nodularis

0.00

0.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

0.0

1.6

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.0

1.7

—

Non-allergic asthma

0.00

0.0

1.9

—

Optic neuritis

0.00

0.0

1.6

—

Dermatitis due to substances taken internally

0.00

0.0

2.0

—

Other diseases of intestines

1.03

0.00

3.0

2.4

—

Other specified/unspecified bacterial intestinal infections

0.00

0.0

1.9

—

Reactive arthropathies

0.00

0.0

2.3

—

Amputation of toe

0.00

0.0

1.5

—

Pain in thoracic spine

0.00

0.0

2.4

—

Benign neoplasm: Skin, unspecified

0.00

0.0

1.7

—

Radiculopathy

0.00

0.0

1.4

—

Amputation of foot

0.00

0.0

1.6

—

Pilonidal cyst

0.00

0.0

2.3

—

Long labour

0.00

0.0

2.0

—

Other disorders of iris and ciliary body

0.00

0.0

1.9

—

Other epidermal thickening

0.00

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.0

2.0

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.8

—

Other Crohn's disease

0.00

0.0

1.6

—

Rubella [German measles]

0.00

0.0

2.8

—

Herpesviral [herpes simplex] infections

0.00

0.0

1.7

—

0.00

0.0

1.8

—

Use of rivastigmine

0.00

0.0

1.4

—

Lichen sclerosus et atrophicus

0.00

0.0

1.6

—

Agranulocytosis

0.00

0.0

1.7

—

Other and unspecified rosacea

0.00

0.0

1.8

—

Cholecystitis

0.00

0.0

1.7

—

Synovial cyst of popliteal space [Baker]

0.00

0.0

1.7

—

Abdominal aortic aneurysm (AAA)

0.00

0.0

1.2

—

Other/unspecified disorders of vestibular function

0.00

0.0

1.2

—

Cardiomyopathy, other and unspecified

0.00

0.0

1.6

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.6

—

Dystonia

0.00

0.0

1.2

—

Hydrocephalus

0.00

0.0

1.2

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

2.0

—

Viral encephalitis, not elsewhere classified/unspecified

0.00

0.0

1.8

—

Other diseases of gallbladder

0.00

0.0

1.6

—

Sicca syndrome [Sjögren]

0.00

0.0

1.8

—

Sequelae of injuries of neck and trunk

0.00

0.0

1.7

—

Sequelae of injuries of head

0.00

0.0

1.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

0.0

1.7

—

Pneumonia derived septicemia

0.00

0.0

1.7

—

Sequelae of injuries of lower limb

0.00

0.0

1.7

—

Hypothermia

0.00

0.0

1.2

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.0

1.5

—

Injury of other and unspecified intrathoracic organs

0.00

0.0

1.9

—

Open wound of hip and thigh

0.00

0.0

1.7

—

Other/unspecified reactive arthropathies

0.00

0.0

1.7

—

Other and unspecified injuries of lower leg

0.00

0.0

1.9

—

Cramp and spasm

0.00

0.0

1.8

—

Elevated blood glucose level

0.00

0.0

1.9

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

1.6

—

Open wound of thorax

0.00

0.0

1.8

—

Other and unspecified injuries of shoulder and upper arm

0.00

0.0

1.2

—

Maltreatment syndromes

0.00

0.0

1.6

—

Rash and other nonspecific skin eruption

0.00

0.0

1.7

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.8

—

Superficial injury of shoulder and upper arm

0.00

0.0

1.4

—

Superficial injury of forearm

0.00

0.0

1.8

—

Event of undetermined intent

0.00

0.0

1.7

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.0

1.8

—

Somnolence, stupor and coma

0.00

0.0

2.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.0

1.2

—

Vascular diseases of the intestine

0.00

0.0

1.5

—

Contact with other hot fluids

0.00

0.0

1.7

—

Exposure to smoke, fire and flames

0.00

0.0

1.7

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.0

1.8

—

Contact with machinery

0.00

0.0

2.6

—

Viral pneumonia (unknown virus, not influenza)

0.00

0.0

1.7

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.0

1.6

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.0

1.8

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.8

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.0

1.6

—

Other abnormal findings of blood chemistry

0.00

0.0

1.7

—

Pedestrian injured in collision with pedal cycle

0.00

0.0

1.7

—

Car occupant injured in noncollision transport accident

0.00

0.0

1.8

—

Need for other prophylactic measures

0.00

0.0

1.7

—

Unspecified misadventure during surgical and medical care

0.00

0.0

1.2

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.0

1.8

—

Special screening examination for neoplasms

0.00

0.0

1.2

—

Preparatory care for dialysis

0.00

0.0

1.7

—

Special screening examination for other diseases and disorders

0.00

0.0

1.1

—

Other orthopaedic follow-up care

0.00

0.0

2.0

—

Congenital malformations of aortic and mitral valves

0.00

0.0

1.8

—

Congenital malformations of cardiac septa

0.00

0.0

1.2

—

Persons encountering health services for specific procedures, not carried out

0.00

0.0

1.9

—

Outcome of delivery

0.00

0.0

1.4

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Isoniazid [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS